Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "Navigating Regulatory Compliance Whilst Developing and Distributing Polymerase Chain Reaction (PCR)-Based IVD Tests Training Course (May 15, 2026)" has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results